Andrew Stone, UK

A consultant biostatistician with Stone Biostatistics who has 24 years of experience in the pharmaceutical industry and held a senior leadership or management position in the oncology TA at AstraZeneca for nearly 10 years.  Consequently, Andrew has significant regulatory experience, leading biostatistics teams to the submission or approval of six oncology products.  Furthermore, Andrew sat on governance committees that approved the design of > 50 pivotal trials.